[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Chimeric Antibody Market Research Report Forecast 2017-2021

June 2017 | 111 pages | ID: U2680EAB1E4EN
S&P Consulting

US$ 2,960.00 US$ 3,700.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The United States Chimeric Antibody Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Chimeric Antibody industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Chimeric Antibody market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:

Agilent Technologies
BD Biosciences
Beckman Coulter
bioMerieux
Bio-Rad Laboratories
F.Hoffmann-La Roche
Gallus Immunotech
GE Healthcare
Lonza Biologics Ltd

United States Chimeric Antibody Market: Product Segment Analysis
  • Type 1
  • Type 2
  • Type 3
United States Chimeric Antibody Market: Application Segment Analysis
  • Application 1
  • Application 2
  • Application 3
Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 CHIMERIC ANTIBODY MARKET OVERVIEW

1.1 Product Overview and Scope of Chimeric Antibody
1.2 Chimeric Antibody Market Segmentation by Type
  1.2.1 United States Production Market Share of Chimeric Antibody by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Chimeric Antibody Market Segmentation by Application
  1.3.1 Chimeric Antibody Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Chimeric Antibody (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON CHIMERIC ANTIBODY INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES CHIMERIC ANTIBODY MARKET COMPETITION BY MANUFACTURERS

3.1 United States Chimeric Antibody Production and Share by Manufacturers (2015 and 2016)
3.2 United States Chimeric Antibody Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Chimeric Antibody Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Chimeric Antibody Manufacturing Base Distribution, Production Area and Product Type
3.5 Chimeric Antibody Market Competitive Situation and Trends
  3.5.1 Chimeric Antibody Market Concentration Rate
  3.5.2 Chimeric Antibody Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES CHIMERIC ANTIBODY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Chimeric Antibody Production and Market Share by Type (2012-2017)
4.2 United States Chimeric Antibody Revenue and Market Share by Type (2012-2017)
4.3 United States Chimeric Antibody Price by Type (2012-2017)
4.4 United States Chimeric Antibody Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES CHIMERIC ANTIBODY MARKET ANALYSIS BY APPLICATION

5.1 United States Chimeric Antibody Consumption and Market Share by Application (2012-2017)
5.2 United States Chimeric Antibody Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES CHIMERIC ANTIBODY MANUFACTURERS ANALYSIS

6.1 Agilent Technologies
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 BD Biosciences
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Beckman Coulter
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 bioMerieux
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Bio-Rad Laboratories
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 F.Hoffmann-La Roche
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Gallus Immunotech
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 GE Healthcare
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Lonza Biologics Ltd
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 CHIMERIC ANTIBODY MANUFACTURING COST ANALYSIS

7.1 Chimeric Antibody Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Chimeric Antibody

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Chimeric Antibody Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Chimeric Antibody Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES CHIMERIC ANTIBODY MARKET FORECAST (2017-2021)

11.1 United States Chimeric Antibody Production, Revenue Forecast (2017-2021)
11.2 United States Chimeric Antibody Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Chimeric Antibody Production Forecast by Type (2017-2021)
11.4 United States Chimeric Antibody Consumption Forecast by Application (2017-2021)
11.5 Chimeric Antibody Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Chimeric Antibody
Table Classification of Chimeric Antibody
Figure United States Sales Market Share of Chimeric Antibody by Type in 2015
Table Application of Chimeric Antibody
Figure United States Sales Market Share of Chimeric Antibody by Application in 2015
Figure United States Chimeric Antibody Sales and Growth Rate (2011-2021)
Figure United States Chimeric Antibody Revenue and Growth Rate (2011-2021)
Table United States Chimeric Antibody Sales of Key Manufacturers (2015 and 2016)
Table United States Chimeric Antibody Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Chimeric Antibody Sales Share by Manufacturers
Figure 2016 Chimeric Antibody Sales Share by Manufacturers
Table United States Chimeric Antibody Revenue by Manufacturers (2015 and 2016)
Table United States Chimeric Antibody Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Chimeric Antibody Revenue Share by Manufacturers
Table 2016 United States Chimeric Antibody Revenue Share by Manufacturers
Table United States Market Chimeric Antibody Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Chimeric Antibody Average Price of Key Manufacturers in 2015
Figure Chimeric Antibody Market Share of Top 3 Manufacturers
Figure Chimeric Antibody Market Share of Top 5 Manufacturers
Table United States Chimeric Antibody Sales by Type (2012-2017)
Table United States Chimeric Antibody Sales Share by Type (2012-2017)
Figure United States Chimeric Antibody Sales Market Share by Type in 2015
Table United States Chimeric Antibody Revenue and Market Share by Type (2012-2017)
Table United States Chimeric Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Chimeric Antibody by Type (2012-2017)
Table United States Chimeric Antibody Price by Type (2012-2017)
Figure United States Chimeric Antibody Sales Growth Rate by Type (2012-2017)
Table United States Chimeric Antibody Sales by Application (2012-2017)
Table United States Chimeric Antibody Sales Market Share by Application (2012-2017)
Figure United States Chimeric Antibody Sales Market Share by Application in 2015
Table United States Chimeric Antibody Sales Growth Rate by Application (2012-2017)
Figure United States Chimeric Antibody Sales Growth Rate by Application (2012-2017)
Table Agilent Technologies Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Agilent Technologies Chimeric Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Agilent Technologies Chimeric Antibody Market Share (2012-2017)
Table BD Biosciences Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BD Biosciences Chimeric Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table BD Biosciences Chimeric Antibody Market Share (2012-2017)
Table Beckman Coulter Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Beckman Coulter Chimeric Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Beckman Coulter Chimeric Antibody Market Share (2012-2017)
Table bioMerieux Basic Information, Manufacturing Base, Production Area and Its Competitors
Table bioMerieux Chimeric Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table bioMerieux Chimeric Antibody Market Share (2012-2017)
Table Bio-Rad Laboratories Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bio-Rad Laboratories Chimeric Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Bio-Rad Laboratories Chimeric Antibody Market Share (2012-2017)
Table F.Hoffmann-La Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table F.Hoffmann-La Roche Chimeric Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table F.Hoffmann-La Roche Chimeric Antibody Market Share (2012-2017)
Table Gallus Immunotech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Gallus Immunotech Chimeric Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Gallus Immunotech Chimeric Antibody Market Share (2012-2017)
Table GE Healthcare Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GE Healthcare Chimeric Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table GE Healthcare Chimeric Antibody Market Share (2012-2017)
Table Lonza Biologics Ltd Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Lonza Biologics Ltd Chimeric Antibody Production, Revenue, Price and Gross Margin (2012-2017)
Table Lonza Biologics Ltd Chimeric Antibody Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chimeric Antibody
Figure Manufacturing Process Analysis of Chimeric Antibody
Figure Chimeric Antibody Industrial Chain Analysis
Table Raw Materials Sources of Chimeric Antibody Major Manufacturers in 2015
Table Major Buyers of Chimeric Antibody
Table Distributors/Traders List
Figure United States Chimeric Antibody Production and Growth Rate Forecast (2017-2021)
Figure United States Chimeric Antibody Revenue and Growth Rate Forecast (2017-2021)
Table United States Chimeric Antibody Production Forecast by Type (2017-2021)
Table United States Chimeric Antibody Consumption Forecast by Application (2017-2021)


More Publications